No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
Biomarkers, Tumor / blood
-
Biomarkers, Tumor / genetics*
-
Bortezomib / therapeutic use
-
Disease Progression
-
Gene Expression
-
Humans
-
Immunoglobulin Light Chains / blood
-
Immunoglobulin Light Chains / genetics*
-
Immunoglobulin M / blood
-
Immunoglobulin M / genetics*
-
Immunoglobulins / blood
-
Immunoglobulins / genetics*
-
Lenalidomide
-
Multiple Myeloma / diagnosis*
-
Multiple Myeloma / genetics
-
Multiple Myeloma / mortality
-
Multiple Myeloma / therapy
-
Prognosis
-
Recurrence
-
Stem Cell Transplantation
-
Survival Analysis
-
Thalidomide / analogs & derivatives
-
Thalidomide / therapeutic use
Substances
-
Antineoplastic Agents
-
Biomarkers, Tumor
-
Immunoglobulin Light Chains
-
Immunoglobulin M
-
Immunoglobulins
-
M-proteins (Myeloma)
-
Thalidomide
-
Bortezomib
-
Lenalidomide